CNR1 and breast cancer: Present results suggest the involvement of both CB1 and CB2 receptors in the control of breast cancer cell proliferation; moreover, the cytotoxicity of FOJ and FOS extracts and of mFOJ and mFOS cocktails seems to be not ascribable to a CB1 receptor modulation, despite an involvement, albeit partial, of CB2 receptors.